ArticleJCI insight2024
An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes.
Farzad Asadi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it